{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T09:49:04Z","timestamp":1768038544308,"version":"3.49.0"},"reference-count":86,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[1999,3,1]],"date-time":"1999-03-01T00:00:00Z","timestamp":920246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>This review discusses the possibility of whether furosemide acyl glucuronide, a metabolite of furosemide, contributes to the clinical effect of diuresis.<\/jats:p>\n               <jats:p>First an analytical method (e.g. HPLC) must be available to measure both parent drug and furosemide acyl glucuronide. Then, with correctly treated plasma and urine samples (light protected, pH 5) from volunteers and furosemide-treated patients, the kinetic curves of both furosemide as well as its acyl glucuronide can be measured. The acyl glucuronide is formed in part by the kidney tubules and it is possible that the compound is pharmacologically active through inhibition of the Na+\/2Cl-\/K+ co-transport system; up to now the mechanism of action has been solely attributed to furosemide.<\/jats:p>\n               <jats:p>The total body clearance of furosemide occurs by hepatic and renal glucuronidation (50%) and by renal excretion (50%). Enterohepatic cycling of furosemide acyl glucuronide, followed by hydrolysis, results in a second and slow elimination phase with a half-life of 20-30h. This slow elimination phase coincides with a pharmacodynamic rebound phase of urine retention. After each dosage of furosemide, there is first a short stimulation of urine flow (4h), which is followed by a 3-day recovery period of the body.<\/jats:p>\n               <jats:p>The following clinical implications arise from study of the elimination kinetics of furosemide. Repetitive dosing must result in accumulation of the recovery period. Accumulation of furosemide and its acyl glucuronide in patients with end-stage renal failure results from infinite hepatic cycling. Impaired kidney function may result in impaired glucuronidation and diuresis. While kidney impairment normally requires a dose reduction for those compounds which are mainly eliminated by renal excretion, for diuretics, a dose increment is required in order to maintain a required level of diuresis.<\/jats:p>\n               <jats:p>The full clinical impact of the accumulation of furosemide and its acyl glucuronide in patients with end-stage renal failure has to be determined.<\/jats:p>","DOI":"10.1211\/0022357991772402","type":"journal-article","created":{"date-parts":[[2003,7,18]],"date-time":"2003-07-18T23:43:52Z","timestamp":1058571832000},"page":"239-248","source":"Crossref","is-referenced-by-count":19,"title":["Clinical Consequences of the Biphasic Elimination Kinetics for the Diuretic Effect of Furosemide and its Acyl Glucuronide in Humans"],"prefix":"10.1093","volume":"51","author":[{"given":"Tom B","family":"Vree","sequence":"first","affiliation":[{"name":"Institute of Anaesthesiology, Academic Hospital Nijmegen Sint Radboud , Geert Grooteplein Zuid 10, 6525 GA Nijmegen,","place":["Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J A M","family":"Van Der Ven Andr\u00e9","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Academic Hospital Maastricht , P.O. Box 5800, 6202AZ Maastricht,","place":["Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1999,3,1]]},"reference":[{"key":"2024103110041957300_cit1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1042\/cs0410171","article-title":"Diuretics in chronic renal disease: a study of high dosage frusemide","volume":"41","author":"Allison","year":"1971","journal-title":"Clin. Sci."},{"key":"2024103110041957300_cit2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1365-2125.1990.tb03622.x","article-title":"Diuretic effect and diuretic efficiency after intravenous dosage of frusemide","volume":"29","author":"Alv\u00e1n","year":"1990","journal-title":"Br. J. Clin. Pharmacol."},{"key":"2024103110041957300_cit3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2125.1992.tb04106.x","article-title":"Discrepancy between bioavailability as estimated from urinary recovery of furosemide and total diuretic effect","volume":"34","author":"Alv\u00e1n","year":"1992","journal-title":"Br. J. Clin. Pharmacol."},{"key":"2024103110041957300_cit4","first-page":"51","article-title":"On the fate of furosemide in man","volume":"9","author":"Beerman","year":"1975","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"2024103110041957300_cit5","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/cpt197722170","article-title":"Elimination of furosemide in healthy subjects and i those with renal failure","volume":"22","author":"Beerman","year":"1977","journal-title":"Clin. Pharmacol. Ther."},{"key":"2024103110041957300_cit6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01059438","article-title":"Pharmacokinetics\/pharmacodynamics of furosemide in man, a review","volume":"7","author":"Benet","year":"1979","journal-title":"J. Pharmacokin. Biopharm."},{"key":"2024103110041957300_cit7","first-page":"1695","article-title":"Furosemide assays and disposition in healthy volunteers and renal transplant patients","volume":"42","author":"Benet","year":"1983","journal-title":"Fed. Proc."},{"key":"2024103110041957300_cit8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1365-2125.1977.tb00682.x","article-title":"Determinants of response to furosemide in normal subjects","volume":"4","author":"Branch","year":"1977","journal-title":"Br. J. Clin. Pharmacol."},{"key":"2024103110041957300_cit9","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/cpt1978245548","article-title":"Effects of probenecid on furosemide response","volume":"24","author":"Brater","year":"1978","journal-title":"Clin. Pharmacol. Ther."},{"issue":"Suppl. 3","key":"2024103110041957300_cit10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2165\/00003495-199100413-00004","article-title":"Clinical pharmacology of loop diuretics","volume":"41","author":"Brater","year":"1991","journal-title":"Drugs"},{"key":"2024103110041957300_cit11","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/clpt.1980.148","article-title":"Furosemide in patients with heart failure: shift in dose response curves","volume":"28","author":"Brater","year":"1980","journal-title":"Clin. Pharmacol. Ther."},{"key":"2024103110041957300_cit12","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/clpt.1986.151","article-title":"Response to furosemide in chronic renal insufficiency: rationale for limited doses","volume":"40","author":"Brater","year":"1986","journal-title":"Clin. Pharmacol. Ther."},{"key":"2024103110041957300_cit13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/ki.1976.20","article-title":"Tubular chloride transport and the mode of action of some diuretics","volume":"9","author":"Burg","year":"1976","journal-title":"Kidney Int."},{"key":"2024103110041957300_cit14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1152\/ajplegacy.1973.225.1.119","article-title":"Furosemide effects on isolated perfused tubules","volume":"225","author":"Burg","year":"1973","journal-title":"Am. J. Physiol."},{"key":"2024103110041957300_cit15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/ki.1979.120","article-title":"Pharmacodynamic analysis of the furosemide-probenecid interaction in man","volume":"16","author":"Chennavasin","year":"1979","journal-title":"Kidney Int."},{"key":"2024103110041957300_cit16","first-page":"77","article-title":"Pharmacokinetic-dynamic analysis of the indomethacin-furosemide interaction in man","volume":"215","author":"Chennavasin","year":"1980","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2024103110041957300_cit17","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/0002-9610(83)90344-6","article-title":"Diuresis with continuous infusion of furosemide after cardiac surgery","volume":"146","author":"Copeland","year":"1983","journal-title":"Am. J. Surg."},{"key":"2024103110041957300_cit18","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/cpt1974156588","article-title":"Pharmacokinetics of furosemide in normal subjects and functionally anephric patients","volume":"15","author":"Cutler","year":"1974","journal-title":"Clin. Pharmacol. Ther."},{"key":"2024103110041957300_cit19","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1056\/NEJM197305242882102","article-title":"Renal and extra renal hemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction","volume":"288","author":"Dikshit","year":"1973","journal-title":"N. Engl. J. Med."},{"key":"2024103110041957300_cit20","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/0735-1097(96)00161-1","article-title":"Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion","volume":"28","author":"Dormans","year":"1996","journal-title":"J. Am. Coll. Cardiol."},{"key":"2024103110041957300_cit21","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/ki.1977.128","article-title":"Effect of furosemide on renal autoregulation","volume":"12","author":"Duchin","year":"1977","journal-title":"Kidney Int."},{"key":"2024103110041957300_cit22","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.3109\/03602538409033562","article-title":"Properties of acyl glucuronides: implications for studies of the pharmacokinetics and metabolism of acidic drugs","volume":"15","author":"Faed","year":"1984","journal-title":"Drug Metab. Rev."},{"key":"2024103110041957300_cit23","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1001\/archinte.1988.00380020030006","article-title":"High dose furosemide in the treatment of refractory congestive heart failure","volume":"148","author":"Gerlag","year":"1988","journal-title":"Arch. Intern. Med."},{"key":"2024103110041957300_cit24","first-page":"453P","article-title":"Continuous infusion of frusemide in refractory oedema","volume":"64","author":"Gray","year":"1978","journal-title":"Br. J. Pharmacol."},{"key":"2024103110041957300_cit25","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/BF01537500","article-title":"Cellular mechanisms of the action of loop diuretics on the thick ascending limb of Henle's loop","volume":"61","author":"Greger","year":"1983","journal-title":"Klin. Wschrft."},{"key":"2024103110041957300_cit26","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF00630286","article-title":"Pharmacokinetics of furosemide in man after intravenous and oral administration. Application of moment analysis","volume":"26","author":"Hammarlund","year":"1984","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"2024103110041957300_cit27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01059086","article-title":"Furosemide pharmacokinetics and pharmacodynamics in health and disease, an update","volume":"17","author":"Hammarlund-Udenaes","year":"1989","journal-title":"J. Pharmacokin. Biopharm."},{"key":"2024103110041957300_cit28","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/10641968309048820","article-title":"Diuretic agents: actions on a molecular level","volume":"A5","author":"Heidenreich","year":"1983","journal-title":"Clin. Exp. Hyper. Theory Practice"},{"key":"2024103110041957300_cit29","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/BF01715815","article-title":"Aktivierung des sympathicoadrenalen Systems nach Diuretica-Beziehungen zum saldiuretischen Effekt und Glomerulumfiltrat","volume":"47","author":"Heidland","year":"1969","journal-title":"Klin. Wschrft."},{"key":"2024103110041957300_cit30","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/cpt1977224402","article-title":"Influence of probenecid and spironolactone on furosemide kinetics and dynamics in man","volume":"22","author":"Homeida","year":"1977","journal-title":"Clin. Pharmacol. Ther."},{"key":"2024103110041957300_cit31","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/cpt1977224395","article-title":"Effects of probenecid on furosemide kinetics and natriuresis in man","volume":"22","author":"Honari","year":"1977","journal-title":"Clin. Pharmacol. Ther."},{"key":"2024103110041957300_cit32","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1146\/annurev.pa.16.040176.001221","article-title":"Diuretics: sites and mechanisms of action","volume":"16","author":"Jacobson","year":"1976","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"2024103110041957300_cit33","first-page":"F374","article-title":"Structural adaptation of the distal convoluted tubule to prolonged furosemide treatment","volume":"248","author":"Kaissling","year":"1985","journal-title":"Am. J. Physiol."},{"key":"2024103110041957300_cit34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2710.1995.tb00620.x","article-title":"Effects of water deprivation for 48 hours on the pharmacokinetics and pharmacodynamics of furosemide in rats","volume":"20","author":"Kang","year":"1995","journal-title":"J. Clin. Pharm. Ther."},{"key":"2024103110041957300_cit35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ki.1982.134","article-title":"The time course of delivery of furosemide into urine: an independent determinant of overall response","volume":"22","author":"Kaojarern","year":"1982","journal-title":"Kidney Int."},{"key":"2024103110041957300_cit36","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF00877961","article-title":"Torasemide in advanced renal failure","volume":"7","author":"Kindler","year":"1993","journal-title":"Cardovasc. Drugs Ther."},{"issue":"Suppl. 3","key":"2024103110041957300_cit37","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2165\/00003495-199100413-00005","article-title":"The loop diuretic torasemide in chronic renal failure. Pharmacokinetics and pharmacodynamics","volume":"41","author":"Knauf","year":"1991","journal-title":"Drugs"},{"key":"2024103110041957300_cit38","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1378\/chest.89.2.294","article-title":"Postoperative enhancement of urinary output in patients with acute renal failure using continuous furosemide therapy","volume":"89","author":"Krasma","year":"1986","journal-title":"Chest"},{"key":"2024103110041957300_cit39","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1378\/chest.102.3.725","article-title":"Intermittent administration of furosemide vs continuous infusion preceded by a loading dose for congestive heart failure","volume":"102","author":"Lahav","year":"1992","journal-title":"Chest"},{"key":"2024103110041957300_cit40","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/bmj.2.6135.476","article-title":"Continuous infusion of frusemide in refractory oedema","volume":"2","author":"Lawson","year":"1978","journal-title":"Br. Med. J."},{"key":"2024103110041957300_cit41","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/bdd.2510070603","article-title":"Effect of intravenous infusion time on the pharmacokinetics and pharmacodynamics of the same total dose of furosemide","volume":"7","author":"Lee","year":"1986","journal-title":"Biopharm. Drug Dispos."},{"key":"2024103110041957300_cit42","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/0003-4975(90)90505-Z","article-title":"Diuresis in hemodynamically compromised patients: continuous furosemide infusion","volume":"50","author":"Magovern","year":"1990","journal-title":"Ann. Thorac. Surg."},{"key":"2024103110041957300_cit43","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/BF00194955","article-title":"Furosemide disposition in patients on CAPD","volume":"48","author":"Martin","year":"1995","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"2024103110041957300_cit44","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/j.1875-9114.1997.tb03681.x","article-title":"Variable furosemide absorption and poor predictability of response in elderly patients","volume":"17","author":"Murray","year":"1997","journal-title":"Pharmacotherapy"},{"key":"2024103110041957300_cit45","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/bdd.2510160307","article-title":"The influence of food intake on the effect of two controlled release formulations of furosemide","volume":"16","author":"Paintaud","year":"1995","journal-title":"Biopharm. Drug Dispos."},{"key":"2024103110041957300_cit46","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1681\/ASN.V72345","article-title":"Role of the kidneys in the metabolism of furosemide: its inhibition by probenecid","volume":"7","author":"Pichette","year":"1996","journal-title":"J. Am. Soc. Nephrol."},{"key":"2024103110041957300_cit47","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/j.1476-5381.1996.tb15755.x","article-title":"The influence of moderate hypoalbuminaemia on the renal metabolism and dynamics of furosemide in the rabbit","volume":"119","author":"Pichette","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"2024103110041957300_cit48","first-page":"381","article-title":"Furosemide. A pharmacokinetic\/pharmacodynamic review","volume":"18","author":"Ponto","year":"1990","journal-title":"Clin. Pharmacokin."},{"key":"2024103110041957300_cit49","first-page":"666","article-title":"The acute effects on acid and electrolyte excretion in man","volume":"71","author":"Puschett","year":"1968","journal-title":"J. Lab. Clin. Med."},{"key":"2024103110041957300_cit50","first-page":"705","article-title":"Furosemide 1-O-acyl glucuronide. In vitro biosynthesis and pH-dependent isomerization to \u03b2-glucuronidase-resistant forms","volume":"13","author":"Rachmel","year":"1985","journal-title":"Drug Metab. Dispos."},{"issue":"Suppl. 3","key":"2024103110041957300_cit51","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2165\/00003495-199100413-00006","article-title":"Effects of diuretics on outputs and flows of urine and urinary solutes in healthy volunteers","volume":"41","author":"Reyes","year":"1991","journal-title":"Drugs"},{"key":"2024103110041957300_cit52","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF00877955","article-title":"Clinicopharmacological reappraisal of the potency of diuretics","volume":"7","author":"Reyes","year":"1993","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"Suppl. 3","key":"2024103110041957300_cit53","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2165\/00003495-199100413-00008","article-title":"The efficacy of diuretics in acute and chronic renal failure","volume":"41","author":"Risler","year":"1991","journal-title":"Drugs"},{"issue":"Suppl. 3","key":"2024103110041957300_cit54","first-page":"40","article-title":"Treatment with high doses of loop diuresis in chronic renal failure","volume":"9","author":"Ritz","year":"1994","journal-title":"Nephrol. Dial. Transplant."},{"key":"2024103110041957300_cit55","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF00637617","article-title":"Kinetics of furosemide in children with chronic renal failure undergoing regular haemodialysis","volume":"21","author":"Riva","year":"1982","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"2024103110041957300_cit56","doi-asserted-by":"crossref","first-page":"360","DOI":"10.7326\/0003-4819-115-5-360","article-title":"Loop diuretics for chronic renal insufficiency: a continuous infusion is more efficacious than bolus therapy","volume":"115","author":"Rudy","year":"1991","journal-title":"Ann. Intern. Med."},{"issue":"Suppl. 1","key":"2024103110041957300_cit57","first-page":"S69","article-title":"The place of loop diuretics in the treatment of acute and chronic renal failure","volume":"38","author":"Russo","year":"1992","journal-title":"Clin. Nephrol."},{"key":"2024103110041957300_cit58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ki.1977.1","article-title":"Site of action of diuretic drugs","volume":"11","author":"Seeley","year":"1977","journal-title":"Kidney Int."},{"key":"2024103110041957300_cit59","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1248\/bpb.18.447","article-title":"Biliary excretion of furosemide glucuronides in rabbits","volume":"18","author":"Sekinawa","year":"1995","journal-title":"Biol. Pharm. Bull."},{"key":"2024103110041957300_cit60","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/00365599.1988.11690399","article-title":"On the mechanism of acute tolerance to furosemide diuresis","volume":"22","author":"Sj\u00f6str\u00f6m","year":"1988","journal-title":"Scand. J. Urol. Nephrol."},{"key":"2024103110041957300_cit61","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF00558227","article-title":"Pharmacokinetics and effects of frusemide in patients with nephrotic syndrome","volume":"37","author":"Sj\u00f6str\u00f6m","year":"1989","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"2024103110041957300_cit62","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/jps.2600690526","article-title":"Preliminary evaluation of furosemide-probenecid interaction in humans","volume":"69","author":"Smith","year":"1980","journal-title":"J. Pharm. Sci."},{"key":"2024103110041957300_cit63","doi-asserted-by":"crossref","first-page":"380","DOI":"10.2165\/00003495-199448030-00005","article-title":"Diuretic strategies in patients with renal failure","volume":"48","author":"Swan","year":"1994","journal-title":"Drugs"},{"key":"2024103110041957300_cit64","first-page":"118","article-title":"Clinical pharmacology of loop diuretics and their use in chronic renal insufficiency","volume":"6","author":"Swan","year":"1993","journal-title":"J. Nephrol."},{"issue":"Suppl. 3","key":"2024103110041957300_cit65","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1097\/00005344-199322003-00006","article-title":"Diuretics in heart failure: some knowns and unknowns","volume":"22","author":"Taylor","year":"1993","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"2024103110041957300_cit66","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/clpt.1992.44","article-title":"Diuretic efficiency of furosemide during continuous administration versus bolus injection in healthy volunteers","volume":"51","author":"VanMeyel","year":"1992","journal-title":"Clin. Pharmacol. Ther."},{"key":"2024103110041957300_cit67","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2796.1994.tb01082.x","article-title":"Continuous infusion of furosemide in the treatment of patients with congestive heart failure and diuretic resistance","volume":"235","author":"VanMeyel","year":"1994","journal-title":"J. Int. Med."},{"key":"2024103110041957300_cit68","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1159\/000168471","article-title":"Acute and long term effects of therapy with high dose furosemide in chronic hemodialysis patients","volume":"12","author":"VanOlden","year":"1992","journal-title":"Am. J. Nephrol."},{"key":"2024103110041957300_cit69","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/BF00193698","article-title":"Sensitivity of residual nephrons to high dose furosemide described by diuretic efficiency","volume":"47","author":"VanOlden","year":"1995","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"2024103110041957300_cit70","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1111\/j.1476-5381.1995.tb15087.x","article-title":"Extrahepatic metabolism of frusemide in anaesthetized rabbits","volume":"116","author":"Verg\u00e9s","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"2024103110041957300_cit71","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/ki.1987.246","article-title":"Comparison of loop diuretics in patients with chronic renal insufficiency","volume":"32","author":"Voelker","year":"1987","journal-title":"Kidney Int."},{"key":"2024103110041957300_cit72","first-page":"8","article-title":"Geneesmiddelen en urine (in)continentie","volume":"19","author":"Vree","year":"1994","journal-title":"Tijdschrft Geneesmiddel Onderzoek T.G.O."},{"key":"2024103110041957300_cit73","first-page":"121","article-title":"Biologische beschikbaarheid van twee furosemide preparaten (biovailability of two furosemide preparations)","volume":"118","author":"Vree","year":"1983","journal-title":"Pharm. Weekbl."},{"key":"2024103110041957300_cit74","first-page":"267","article-title":"Some consequences of drug choice and dosage regimen for patients with impaired kidney function","volume":"17","author":"Vree","year":"1983","journal-title":"Drug Intell. Clin. Pharm."},{"key":"2024103110041957300_cit75","first-page":"325","article-title":"Capacity limited renal glucuronidation of probenecid by humans. A pilot Vmax finding study","volume":"14","author":"Vree","year":"1992","journal-title":"Pharm. Weekbl. Sci."},{"key":"2024103110041957300_cit76","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1177\/106002809202601116","article-title":"Contribution of the human kidney to the metabolic clearance of drugs","volume":"26","author":"Vree","year":"1992","journal-title":"Ann. Pharmacother."},{"key":"2024103110041957300_cit77","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2125.1993.tb04171.x","article-title":"Pharmacokinetics of naproxen, its metabolite O-desmethylnaproxen and their acyl glucuronides in humans. Effect of cimetidine","volume":"35","author":"Vree","year":"1993","journal-title":"Br. J. Clin. Pharmacol."},{"key":"2024103110041957300_cit78","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/bdd.2510140605","article-title":"Pharmacokinetics of naproxen, its metabolite O-desmethylnaproxen and their acyl glucuronides in humans","volume":"14","author":"Vree","year":"1993","journal-title":"Biopharm. Drug Dispos."},{"key":"2024103110041957300_cit79","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0378-4347(94)00093-X","article-title":"Determination of furosemide with its acyl glucuronide in human plasma and urine by means of direct gradient high performance liquid chromatographic analysis with fluorescence detection. Preliminary pharmacokinetics and effect of probenecid","volume":"655","author":"Vree","year":"1994","journal-title":"J. Chromatogr."},{"key":"2024103110041957300_cit80","first-page":"692","article-title":"Probenecid inhibits the renal clearance of frusemide and its acyl glucuronide","volume":"39","author":"Vree","year":"1995","journal-title":"Br. J. Clin. Pharmacol."},{"key":"2024103110041957300_cit81","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/j.2042-7158.1995.tb03278.x","article-title":"Frusemide and its acyl glucuronide show a short and long phase in elimination kinetics and pharmacodynamic effect in man","volume":"47","author":"Vree","year":"1995","journal-title":"J. Pharm. Pharmacol."},{"key":"2024103110041957300_cit82","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2165\/00044011-199509010-00008","article-title":"Pharmacokinetics of sulfamethoxazole with its hydroxy metabolites and N4-acetyl-, N1-glucuronide conjugates in healthy human volunteers","volume":"9","author":"Vree","year":"1995","journal-title":"Clin. Drug Invest."},{"key":"2024103110041957300_cit83","first-page":"137","article-title":"Pharmacokinetics and pharmacodynamics of furosemide and its acyl glucuronide in humans. A quest for the in vivo activity of the acyl glucuronide","volume":"1","author":"Vree","year":"1996","journal-title":"J. Appl. Ther."},{"key":"2024103110041957300_cit84","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0009-9236(96)90170-8","article-title":"Pharmacodynamic modeling of furosemide tolerance after multiple intravenous administration","volume":"60","author":"Wakelkamp","year":"1996","journal-title":"Clin. Pharmacol. Ther."},{"issue":"Suppl. 3","key":"2024103110041957300_cit85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-199100413-00003","article-title":"How do loop diuretics act","volume":"41","author":"Wittner","year":"1991","journal-title":"Drugs"},{"key":"2024103110041957300_cit86","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1248\/bpb.19.616","article-title":"Bioavailability and diuretic effect of furosemide following administration of tablets and retarded capsules to human subjects","volume":"19","author":"Yagi","year":"1996","journal-title":"Biol. Pharm. Bull."}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1211%2F0022357991772402","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/51\/3\/239\/60262696\/0022357991772402.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/51\/3\/239\/60262696\/0022357991772402.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T10:37:01Z","timestamp":1730371021000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/51\/3\/239\/6156825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,3,1]]},"references-count":86,"journal-issue":{"issue":"3","published-online":{"date-parts":[[1999,3,1]]},"published-print":{"date-parts":[[1999,3,1]]}},"URL":"https:\/\/doi.org\/10.1211\/0022357991772402","relation":{},"ISSN":["0022-3573","2042-7158"],"issn-type":[{"value":"0022-3573","type":"print"},{"value":"2042-7158","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1999,3]]},"published":{"date-parts":[[1999,3,1]]}}}